,13 In addition, our group previously showed that the molecular subtypes of SCLC are also linked with different prognostic outcomes since high ASCL1 expression is associated with poor survival, whereas high POU2F3 expression is linked with improved prognosis.12 Here, ASCL1 is linked to small cell lung carcinoma.